Skip to content

Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJNeurology
    • VJDementia
    • VJRegenmed
    • VJHemOnc-E
  • About
    • Supporter
    • Partnerships
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJOncology
Logo
  • Diseases
    Genitourinary
    Lung
    Breast
    Head and Neck
    Gastrointestinal
    Skin
    Gynecological
    Brain Tumor
    Sarcoma
    View all Diseases
  • Topics
    CAR-T & Cellular Therapy
    Molecular Profiling
    Nursing
    Radiotherapy
    Policy
    Screening
    Immuno-Oncology
    Surgery
    Real-World Data
    View all Topics
  • Conferences
  • Features
  • VJSessions
  • Podcasts
    • About
      • Supporter
      • Partnerships
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Thoracic Cancer

Challenges in diagnosing and treating NUT carcinoma 1:32
Challenges in diagnosing and treating NUT carcinoma
Jia Luo • 20 Sep 2023
Optimal chemotherapy regimens for NUT carcinoma 3:00
Optimal chemotherapy regimens for NUT carcinoma
Jia Luo • 20 Sep 2023
An overview of NUT carcinomas 1:53
An overview of NUT carcinomas
Jia Luo • 20 Sep 2023
Multi-modality treatment in thoracic PNET 4:31
Multi-modality treatment in thoracic PNET
Akif Turna • 29 Aug 2023
Radiotherapy highlights at TTLC 2022 1:06
Radiotherapy highlights at TTLC 2022
Charles Simone • 28 Feb 2022
Optimizing CAR T-cell therapies for thoracic cancers 1:28
Optimizing CAR T-cell therapies for thoracic cancers
Prasad Adusumilli • 8 Mar 2022
The role of radiotherapy in mesothelioma and thymic carcinoma 1:29
The role of radiotherapy in mesothelioma and thymic carcinoma
Charles Simone • 28 Feb 2022
Proton therapy in thoracic cancer and mesothelioma 1:27
Proton therapy in thoracic cancer and mesothelioma
Charles Simone • 28 Feb 2022
Nintedanib plus steroid taper in radiation pneumonitis 3:11
Nintedanib plus steroid taper in radiation pneumonitis
Zachary Moore • 14 Sep 2021
Impact of autoimmune disease co-occurring with thymic epithelial tumors and Good’s syndrome 3:09
Impact of autoimmune disease co-occurring with thymic epithelial tumors and Good’s syndrome
Margaret Ottaviano • 2 Feb 2021
ccfDNA to monitor the biological course of thymic epithelial tumors 3:43
ccfDNA to monitor the biological course of thymic epithelial tumors
Margaret Ottaviano • 2 Feb 2021
Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results 2:28
Lurbinectedin monotherapy is active in progressive malignant pleural mesothelioma: SAK 17/16 results
Yannis Metaxas • 29 Sep 2019
Tackling urgent questions in EGFRm NSCLC 2:44
Tackling urgent questions in EGFRm NSCLC
Nicolas Girard • 8 Sep 2017
Toxicity: immunotherapy vs chemotherapy 2:09
Toxicity: immunotherapy vs chemotherapy
Benjamin Besse • 8 Sep 2017
Exciting results from the ALEX trial 2:23
Exciting results from the ALEX trial
Silvia Novello • 8 Sep 2017
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • VJ Sessions
  • Features
  • Podcasts
Newsletter

Receive the latest news and videos from VJOncology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJOncology logo
The content of VJOncology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy